(Q41698383)

7 October 2017

1 reference

title

Inverse agonism and the regulation of receptor number (English)

1 reference

7 October 2017

Milligan G

1

1 reference

7 October 2017

Bond RA

series ordinal

2

1 reference

7 October 2017

publication date

1 December 1997

1 reference

Trends in Pharmacological Sciences

7 October 2017

published in

1 reference

7 October 2017

volume

18

1 reference

7 October 2017

issue

12

1 reference

7 October 2017

page(s)

468-474

1 reference

Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Regulation of basal adenylate cyclase activity in neuroblastoma x glioma hybrid, NG108-15, cells transfected to express the human beta 2 adrenoceptor: evidence for empty receptor stimulation of the adenylate cyclase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Secretion of protease nexin-1 by C6 glioma cells is under the control of a heterotrimeric G protein, Go1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Analysis of inverse agonism at the delta opioid receptor after expression in Rat 1 fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

A constitutively active mutant of the alpha 1B-adrenergic receptor can cause greater agonist-dependent down-regulation of the G-proteins G9 alpha and G11 alpha than the wild-type receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Regulation of receptor expression by agonists: transcriptional and post-transcriptional controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

The dynamic role of palmitoylation in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Beta-adrenergic receptor kinase (GRK2) colocalizes with beta-adrenergic receptors during agonist-induced receptor internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Up-regulation of a constitutively active form of the beta2-adrenoceptor by sustained treatment with inverse agonists but not antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Okadaic acid increases nerve growth factor secretion, mRNA stability, and gene transcription in primary cultures of cortical astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster alpha1B-adrenoceptor by ligands that act as inverse agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Signalling and regulation of the alpha 1B-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

The stoichiometry of expression of protein components of the stimulatory adenylyl cyclase cascade and the regulation of information transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Constitutive activation of muscarinic receptors by the G-protein Gq.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

Propranolol treatment externalizes beta-adrenergic receptors in guinea pig myocardium and prevents further externalization by ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901139-5

7 January 2021

10.1016/S0165-6147(97)01139-5

Identifiers

DOI

1 reference

7 October 2017

1 reference